Investor Hub

Novavax is a global biotechnology company focused on developing our R&D assets and establishing partnerships to maximize the impact of our cutting-edge technology in protecting health.

Latest quarterly earnings
Download PDF
Latest investor presentation
Download PDF
Annual report
Download PDF
Latest publications
See our research
Pipeline
View our pipeline
NASDAQ:NVAX
Loading data...
Stock details
NASDAQ:NVAX
Loading data...
Stock details
Latest quarterly earnings
Download PDF
Latest investor presentation
Download PDF
Annual report
Download PDF
Latest publications
See our research
Pipeline
View our pipeline
Latest press releasesEvents & presentationsReports & financialsSEC filingsStock details & analyst coverage
Press releases & statements
Nov 12, 2025
Corporate and finance

Novavax to Participate in Jefferies London Healthcare Conference

Read full article
Download
Nov 6, 2025
Corporate and finance

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Read full article
Download
View all press releases
Latest press releases
Press releases & statements
Nov 12, 2025
Corporate and finance

Novavax to Participate in Jefferies London Healthcare Conference

Read full article
Download
Nov 6, 2025
Corporate and finance

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Read full article
Download
View all press releases
Events & presentationsReports & financialsSEC filingsStock details & analyst coverage

Corporate governance

Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings and more.

Shareholders seeking information can contact investor relations at (240) 268-2022 or contact us.

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.

Sign up for investor updates